Leading Regenerative Medicine and Bio-pharmaceutical Company augments Zycus’ Procurement Solution to keep pace with its innovation spree

Princeton, NJ, January 30, 2020: Zycus, a leading global provider of comprehensive and end-to-end Source-to-Pay software suite has announced that a US based leading regenerative medicine and biopharmaceutical company has entered into a 4-year license agreement with Zycus for its P2P, supplier  and iConsole solutions and the deployment of the suite shall commence shortly.

The organization was looking for opportunities to enhance its operational excellence by automating their manual and time-consuming workflows, maximize visibility into the procurement processes and bring overall spend under management. This was essentially to drive impact through savings which directly reflects on the bottom line.

Zycus could demonstrate how its P2P solution could help the Procurement and AP teams progress and bring a great deal of additional spend under management while limiting additional personnel investment for both teams. The leading Source-to-Pay provider was also able to address the customer’s compliance concerns with SOX and purchasing policies. These core competencies which were in-line with the customer’s requirements, along with the ease-of-use of its solutions, helped Zycus to differentiate itself from other technology providers that the organization was evaluating.

“We are excited to have this organization on-board that not only encourages innovation in its products but also in its internal processes. With multiple complex requirements for sustaining its continuous innovation in regenerative medicine, it is pertinent for the organization to capture maximum efficiency and structure. Zycus’ implementation here will help the client reduce wastage of time, effort and money; boosting the bottom-line indirectly.” said Gregg Monastiero, Senior Vice President Sales – US, Zycus Inc.